Bruker Q1 Earnings Call Highlights

1 hour ago 2

MarketBeat

Wed, May 6, 2026 astatine 9:55 AM CDT 8 min read

Bruker logo

Key Points

Bruker bushed Q1 expectations with reported gross of $823.4 million (up 2.7% YoY) though integrated gross declined astir 4.4%; non‑GAAP EPS was $0.31 and margins were down year‑over‑year but up of forecasts.
Bookings momentum was led by AI‑driven semiconductor metrology, SciY software, and information detection — each delivered >20% integrated bookings growth, with semimetrology present a >$300 million yearly concern (SciY ~$50M, information ~$70M).
Management raised expected outgo savings to astir $140 million annualized, generated $71 million operating currency flow, paid down $180 million of indebtedness (net leverage 2.9x), and reaffirmed FY26 guidance of $3.57–3.60 billion gross and $2.10–2.15 non‑GAAP EPS.
Interested successful Bruker Corporation? Here are 5 stocks we similar better.

Bruker (NASDAQ:BRKR) reported first-quarter 2026 results that absorption said came successful “well up of expectations,” adjacent arsenic the institution continued to look unit from U.S. world request weakness arsenic good arsenic tariff and currency headwinds.

President and CEO Frank Laukien told investors that portion year-over-year comparisons remained challenging, the institution was encouraged by improving bid trends. “In the archetypal quarter, our Bruker Scientific Instruments conception oregon BSI bookings grew organically successful the precocious azygous digits,” Laukien said, citing spot successful concern probe orders and “encouraging double-digit bookings maturation year-over-year successful world orders from extracurricular the United States.”

Quarterly show and cardinal headwinds

→ 3 Emerging Markets ETFs to Maximize Exposure to High-Potential Countries

Bruker posted first-quarter reported gross of $823.4 million, up 2.7% twelvemonth implicit year. Laukien said overseas speech provided a 4.5% tailwind and acquisitions contributed 2.6%, which much than offset an integrated gross diminution of 4.4%.

On profitability, Laukien said non-GAAP gross borderline and operating borderline were 50% and 10.2%, respectively, some down twelvemonth implicit twelvemonth but “ahead of expectations.” Non-GAAP diluted EPS was $0.31, down from $0.47 successful the prior-year quarter, though Laukien said the effect was “meaningfully up of our anterior expectations.”

→ The Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It Launches

EVP and CFO Gerald Herman attributed borderline unit to aggregate factors, including little measurement and mix, overseas exchange, and tariffs. Herman said non-GAAP operating borderline declined 250 ground points twelvemonth implicit year, reflecting: